2014China Modern DoctorRequires access

Efficacy of acarbose and metformin in treatment of type 2 diabetes

Bian Yuhu

Open publisher page 1 citations

Abstract

Objective To observe the effect acarbose and metformin in treatment of type 2 diabetes. Methods Sixty-four cases of type 2 diabetes patients were treated strictly controlled diet,exercise,on the basis of each group to metformin0.5 g,orally,3 times / d,observation group were treated with acarbose 50 mg,3 times / d,lunch and dinner orally,if blood glucose control was not satisfactory,gradually increased dose to 100 mg/times,for 12 weeks.The efficacy of the two groups were compared. Results The fasting blood glucose were observed before the treatment group and the control group of patients and 2 h postprandial blood glucose compared with no significant difference(P 0.05), lower than before treatment and after treatment,fasting blood glucose and meal after 2 h plasma glucose was(8.3±1.6) mmol/L,(10.2±1.5) mmol/L,respectively,significantly lower than the control group(P0.05). After 12 weeks of treatment,the total curative rate was 93.8%(30/32) in the observation group, the total efficacy rate of the control group was 71.9%(23/32),the difference was significant group between the two groups(χ2=6.387,P0.05). Conclusion Acarbose and metformin in treatment of type 2 diabetes can significantly improve the efficacy,control blood sugar levels,safety,worthy of promotion and application.

About this research paper

What this paper is about

Objective To observe the effect acarbose and metformin in treatment of type 2 diabetes. Methods Sixty-four cases of type 2 diabetes patients were treated strictly controlled diet,exercise,on the basis of each group to metformin0.5 g,orally,3 times / d,observation group were treated with acarbose 50 mg,3 times / d,lunch and dinner orally,if blood glucose control was not satisfactory,gradually increased dose to 100 mg/times,for 12 weeks.The efficacy of the two groups were compared. Results The fasting blood glucose were observed before the treatment group and the control group of patients and 2 h postprandial blood glucose compared with no significant difference(P 0.05), lower than before treatment and after treatment,fasting blood glucose and meal after 2 h plasma glucose was(8.3±1.6) mmol/L,(10.2±1.5) mmol/L,respectively,significantly lower than the control group(P0.05). After 12 weeks of treatment,the total curative rate was 93.8%(30/32) in the observation group, the total efficacy rate of the control group was 71.9%(23/32),the difference was significant group between the two groups(χ2=6.387,P0.05). Conclusion Acarbose and metformin in treatment of type 2 diabetes can significantly improve the efficacy,control blood sugar levels,safety,worthy of promotion and application.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect acarbose and metformin in treatment of type 2 diabetes. Methods Sixty-four cases of type 2 diabetes patients were treated strictly controlled diet,exercise,on the basis of each group to metformin0.5 g,orally,3 times / d,observation group were treated with acarbose 50 mg,3 times / d,lunch and dinner orally,if blood glucose control was not satisfactory,gradually increased dose to 100 mg/times,for 12 weeks.The efficacy of the two groups were compared. Results The fasting blood glucose were observed before the treatment group and the control group of patients and 2 h postprandial blood glucose compared with no significant difference(P 0.05), lower than before treatment and after treatment,fasting blood glucose and meal after 2 h plasma glucose was(8.3±1.6) mmol/L,(10.2±1.5) mmol/L,respectively,significantly lower than the control group(P0.05). After 12 weeks of treatment,the total curative rate was 93.8%(30/32) in the observation group, the total efficacy rate of the control group was 71.9%(23/32),the difference was significant group between the two groups(χ2=6.387,P0.05). Conclusion Acarbose and metformin in treatment of type 2 diabetes can significantly improve the efficacy,control blood sugar levels,safety,worthy of promotion and application.

Key concepts: Acarbose, Medicine, Postprandial, Metformin, Type 2 diabetes, Internal medicine, Blood sugar, Diabetes mellitus

Related papers

Back to paper searchBrowse research topicsOriginal source
Efficacy of acarbose and metformin in treatment of type 2 diabetes — Research Paper | ScholarLens